- Previous Close
98.22 - Open
97.00 - Bid 96.30 x --
- Ask 96.80 x --
- Day's Range
95.18 - 99.60 - 52 Week Range
19.47 - 165.21 - Volume
745,804 - Avg. Volume
891,421 - Market Cap (intraday)
6.073B - Beta (5Y Monthly) -0.63
- PE Ratio (TTM)
166.03 - EPS (TTM)
0.58 - Earnings Date --
- Forward Dividend & Yield 0.40 (0.42%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
--
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.
www.hobiotech.comRecent News: 688656.SS
View MorePerformance Overview: 688656.SS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688656.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688656.SS
View MoreValuation Measures
Market Cap
6.07B
Enterprise Value
6.07B
Trailing P/E
166.03
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.19
Price/Book (mrq)
7.48
Enterprise Value/Revenue
15.08
Enterprise Value/EBITDA
68.25
Financial Highlights
Profitability and Income Statement
Profit Margin
9.15%
Return on Assets (ttm)
2.79%
Return on Equity (ttm)
4.54%
Revenue (ttm)
402.34M
Net Income Avi to Common (ttm)
36.8M
Diluted EPS (ttm)
0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
121.63M
Total Debt/Equity (mrq)
14.25%
Levered Free Cash Flow (ttm)
-48.66M